Treatment
Treatment clinical trials
We’re tracking 8,312 recruiting studies that include Treatment, each written for real people, not researchers, below.
Recruiting studies
- NCT07629843Recruiting
Laser treatment for varicose veins
This study looks at how well laser treatment works for varicose veins and how satisfied patients are with it. It aims to see if this treatment is safe and effective for people with common or recurring varicose veins.
ParisAges 18 years+ - NCT07243561RecruitingPhase 1/Phase 2
Exosome therapy for childhood autism study
This trial tests if exosomes from stem cells can help children with autism who haven't improved enough with standard behavioral therapy. It aims to see if this treatment is safe and effective for reducing autism symptoms.
Dongfang, HainanAges 3–7 - NCT06764875RecruitingPhase 3
New drug combo for HER2-positive stomach cancer
This trial tests a new immunotherapy called rilvegostomig combined with standard chemotherapy and a targeted therapy (trastuzumab deruxtecan) for people with advanced HER2-positive stomach or gastroesophageal junction cancer that has not been treated before.
Anchorage, AlaskaAges 18 years+ - NCT04790253Recruiting
Check brain radiation timing or frequent MRI scans for SCLC
This study compares two ways to follow and treat small-cell lung cancer in the brain: preventive brain radiation versus close monitoring with MRI scans and treatment only if needed. It may help people avoid unnecessary brain treatment or choose the safer timing strategy.
GrazAges 18 years+ - NCT07392255RecruitingPhase 1/Phase 2
Testing CTx001 for geographic atrophy (GA) in AMD
This trial is testing a new treatment called CTx001 for people with geographic atrophy (GA), a late stage of dry age-related macular degeneration (AMD). The goal is to see if the treatment is safe and can slow vision loss.
Carmel, IndianaAges 55 years+ - NCT06774027Recruiting
Breast cancer antibody-drug conjugate treatment registry
This study tracks how well antibody-drug conjugates (ADCs) work for breast cancer that has spread. You may join if you are about to start your first or second ADC for hormone receptor-positive/HER2-negative or triple-negative breast cancer.
San Francisco, CaliforniaAges 18 years+ - NCT07502859RecruitingEarly Phase 1
BEN301 injection for autoimmune diseases
This trial tests an investigational drug called BEN301 for people with certain autoimmune diseases like systemic sclerosis, rheumatoid arthritis, Sjögren's syndrome, or myositis. It aims to see if the drug can help control the disease and improve symptoms.
Beijing, Beijing MunicipalityAges 18–70 - NCT07872553RecruitingPhase 4
Kidney cancer treatment preference study
This study looks at how kidney cancer patients feel about getting their treatment at home versus at the clinic, and asks their doctors for their views too. It is for patients already on certain standard treatments and aims to understand preferences that may improve care.
Basking Ridge, New JerseyAges 18 years+ - NCT07518810RecruitingPhase 2/Phase 3
Testing butylphthalide for multiple system atrophy
This study tests whether a drug called butylphthalide can safely help people with multiple system atrophy (MSA), a rare brain disorder that affects movement and automatic body functions like blood pressure. Participating may help slow the progression of symptoms and improve quality of life.
Nanning, GuangxiAges 30–80 - NCT04674969Recruiting
Register patients receiving a drug-eluting device for leg arteries
This study is a real-world registry that follows adults who receive a drug-eluting device for narrowed or blocked blood vessels in the legs (peripheral vasculature). It helps researchers understand how these devices perform in everyday care.
Jonesboro, ArkansasAges 18 years+ - NCT07674654RecruitingPhase 3
Long-term safety study of an investigational migraine medication
This study is testing the long-term safety of an investigational migraine medication called elismetrep. It is for people who have already completed a previous study of this drug and are willing to continue using a smartphone app to track their symptoms daily.
Birmingham, AlabamaAges 18 years+ - NCT06471036Recruiting
Improving cholesterol testing and treatment after a heart attack
This study tests whether giving extra education to doctors and patients can help improve cholesterol management after a heart-related hospitalization. It aims to see if a simple program can make sure patients get the right testing and treatment for high cholesterol.
Minneapolis, MinnesotaAges 18 years+ - NCT07610395RecruitingPhase 2
Testing an oral drug for cold virus in COPD patients
This trial tests an oral medication (VPV) to see if it can safely treat rhinovirus (a common cold virus) in people with COPD. The goal is to help you recover faster and prevent serious COPD flare-ups.
Mobile, AlabamaAges 40–85 - NCT07562152RecruitingPhase 3
Atebimetinib Plus Gemcitabine/Nab-Paclitaxel for New Pancreatic Cancer
This trial tests a combination of three drugs—atebimetinib (a new targeted therapy), gemcitabine, and nab-paclitaxel (two standard chemotherapy drugs)—as a first treatment for pancreatic cancer that has spread beyond the pancreas. The goal is to see if adding atebimetinib helps patients live longer and feel better.
Huntsville, AlabamaAges 18 years+ - NCT07571928RecruitingPhase 1/Phase 2
New hormone treatment for men with no sperm
This study tests a new medication called leflutrozole for men with a condition where no sperm is produced (azoospermia). The drug may help increase hormone levels that support sperm production, potentially improving fertility.
HerlevAges 18–55 - NCT07868354RecruitingPhase 1
Switching to a new weight-loss medicine from tirzepatide
This study tests how well adults with overweight or obesity, with or without type 2 diabetes, tolerate switching from their current weight-loss medication (tirzepatide) to a new medicine called zenagamtide. It may help you understand if this new option is easier on your stomach.
Glendale, CaliforniaAges 18 years+ - NCT07403331Recruiting
Nerve pain in legs: spinal cord stimulation plus team care
This trial tests a treatment bundle that combines a spinal cord stimulator (a device that sends mild electrical pulses to your spine to block pain signals) with a team of specialists (like a psychologist and physical therapist) to reduce chronic nerve pain in the legs and improve your ability to move and function.
OsloAges 18–60 - NCT07805954RecruitingPhase 3
New targeted pills for first-line metastatic pancreatic cancer
This trial tests two new targeted pills (zoldonrasib and daraxonrasib) compared to the standard chemotherapy (gemcitabine and nab-paclitaxel) as the first treatment for metastatic pancreatic cancer with a specific KRAS G12D mutation. The new pills may specifically attack cancer cells with this mutation.
Phoenix, ArizonaAges 18 years+ - NCT07589387Recruiting
Combined care for diabetes and blood pressure in Nigeria
This study looks at how to improve care for people who have both diabetes and high blood pressure in Nigeria. It aims to help patients manage their conditions better by offering integrated treatment and support.
AbajiAges 18 years+ - NCT07868913RecruitingPhase 2
Ketamine and therapy for suicidal thoughts in the ER
This study tests whether a single dose of ketamine, given by injection in the emergency department, combined with brief psychotherapy, can quickly reduce suicidal thoughts and keep you safe. It aims to find fast-acting relief for people in crisis, possibly helping you feel better sooner and reducing the risk of future attempts.
Fort Hood, TexasAges 18–70 - NCT07192952RecruitingPhase 3
Long-term safety of finerenone for children with heart failure
This trial tests a medicine called finerenone to see if it is safe for children and young adults with heart failure when taken for a long time. It may help improve heart function and manage symptoms.
Aurora, ColoradoAges Up to 18 years - NCT07708961RecruitingPhase 2
Temozolomide with or without WSD0922-FU for EGFR-mutant glioblastoma
This trial tests whether adding a new drug, WSD0922-FU, to standard chemotherapy (temozolomide) works better than temozolomide alone for a specific type of glioblastoma that has an EGFR mutation. It is for patients who have completed radiation and temozolomide together but haven't started maintenance temozolomide yet.
Scottsdale, ArizonaAges 18 years+ - NCT07874503RecruitingPhase 1
Corneal cell implant for corneal swelling
This trial tests a new treatment that implants donated corneal cells attached to a tiny gel onto the back of the cornea. It aims to reduce swelling and improve vision in people with corneal conditions like Fuchs dystrophy or swelling after cataract surgery.
San SalvadorAges 21 years+ - NCT07592299Recruiting
New heat-free treatment for enlarged prostate symptoms
This study tests a new device that uses electrical pulses to treat an enlarged prostate without surgery or heat. It aims to relieve urinary symptoms like weak flow and frequent urination, and may be an option if you have moderate to severe symptoms.
Germantown, TennesseeAges 45 years+
Common questions
- Are there clinical trials studying Treatment?
- Yes. Clin2 currently lists 8,312 recruiting studies that include Treatment, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Treatment trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Treatment an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Treatment or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.